Publikationen SOMA.CK
-
Aktuelle Publikationen
Why symptom burden in non-dialysis CKD matters.
Shedden-Mora M, Jessen B, Huber T.
American Journal of Kidney Diseases 2024; 84(6), 672–673. doi:10.1053/j.ajkd.2024.07.005Predictors of somatic symptom persistencein patients with chronic kidney disease (SOMA.CK): study protocol for a mixed-methodscohort study.
Shedden Mora M, Jessen B, Schmidt-Lauber C, Löwe B, Rösch M, Dannenmeyer H, Gloy J, Van den Bergh O, Huber T.
BMJ Open 2022;12:e067821. doi:10.1136/bmjopen-2022-067821 -
Vorarbeiten
Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
Löwe B, Levenson J, Depping M, Husing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint A, Uhlenbusch N, Weigel A.
PSYCHOL MED. 2021:1-17.Early psychological interventions for somatic symptom disorder and functional somatic syndromes: a systematic review and meta-analysis.
Berezowski L, Ludwig L, Martin A, Löwe B, Shedden-Mora MC.
PSYCHOSOMATIC MEDICINE. 2021; Online ahead of print.Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews.
Alberts J, Löwe B, Glahn MA, Petrie KJ, Laferton J, Nestoriuc Y, Shedden-Mora MC.
BMJ OPEN. 2020;10:e036169.SARS-CoV-2-renal tropism is associated with disease severity and acute kidney injury.
Braun F, Luetgehetmann M, Pferfferle S, Wong M, Carsten A, Lindenmeyer M, Noerz, D, Heinrich F, Meißner K, …, Huber TB.
LANCET. 2020: August 17.Multiorgan and Renal Tropism of SARS-CoV-2.
Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, …, Huber TB.
N ENGL J MED. 2020: May 13.Stepped, collaborative, coordinated care for somatic symptom and related disorders (Sofu-Net) - A mixed-methods evaluation among health care professionals.
Shedden-Mora MC, Kuby A, Tönnies J, Piontek K, Löwe B.
ZEITSCHRIFT FÜR PSYCHOLOGIE. 2020;228(2):119-29.Optimizing expectations about cancer treatment: Results of the randomized controlled PSY-BREAST trial.
Shedden-Mora MC, Pan Y, Heisig SR, Blanckenburg Pv, Rief W, Witzel I, Albert U-S, Nestoriuc Y. CLINICAL PSYCHOLOGY IN EUROPE. 2020;2(1):e2695.ARP3 Controls the Podocyte Architecture at the Kidney Filtration Barrier.
Schell C, Sabass B, Helmstaedter M, Geist F, Abed A, Yasuda-Yamahara M, Sigle A, Maier JI, Grahammer F, …, Huber TB.
DEV CELL. 2018:47(6):741-757.e8.Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment.
Laferton JAC, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC.
FRONT PSYCHOL. 2017;8(233).Effectiveness of a stepped, collaborative, and coordinated health care network for somatoform disorders (Sofu-Net): A controlled cluster cohort study.
Löwe B, Lau K, Daubmann A, Härter M, Wegscheider K, König H-H, Shedden-Mora MC.
PSYCHOSOM MED. 2017;79(9):1016-24.The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.
Schell C, Rogg M, Suhm M, Helmstädter M, Sellung D, Yasuda-Yamahara M, Kretz O, Kättner V, Suleiman H, …, Huber TB.
PROC NATL ACAD SCI USA 2017:114(23):E4621-E4630.mTORC2 critically regulates renal potassium handling.
Grahammer F, Nesterov V, Ahmed A, Steinhardt F, Sandner L, Arnold F, Cordts T, Negrea S, Bertog M, …, Huber TB.
J CLIN INVEST. 2016;126(5):1773-82. -
Vorträge
Symptom perception in chronic kidney disease – an expert survey among nephrologists (SOMA.CK study)
Jessen B, Schmidt-Lauber C, Huber T, Löwe B, Shedden Mora M.
European Association of Psychosomatic Medicine, 12.-15. Juni 2024, Lausanne.
[Poster]Do patients with a chronic kidney disease perceive more symptoms after negative affect induction? An experimental study.
Jessen B, Schmidt-Lauber C, Huber T, Löwe L, Shedden Mora M.
European Association of Psychosomatic Medicine, 15.-17. Juni 2023, Wroclaw.
[Vortrag, 16. Juni 2023]Symptomwahrnehmung nach negativer Affektinduktion bei Patient:innen mit chronischer Nierenerkrankung - eine experimentelle Studie
Jessen B, Schmidt-Lauber C, Huber TB, Löwe B, Shedden Mora M.
Deutscher Psychotherapie Kongress, 10.-13. Mai 2023, Berlin.
[Poster]Prädiktoren für die Persistenz somatischer Symptome bei Patient:innen mit chronischer Nierenerkrankung: SOMACROSS Projekt 3
Shedden Mora M, Jessen B, Schmidt-Lauber C, Huber T.
Deutscher Kongress für Psychosomatische Medizin und Psychotherapie, 22.-24. Juni 2022, Berlin.
[Vortrag, 23. Juni 2022]Predictors of Somatic Symptom Persistence in Patients with Chronic Kidney Disease (SOMA.CK). Project 3 of the SOMACROSS research unit
Shedden Mora M, Jessen B, Schmidt-Lauber C, Löwe B, Huber T
European Association of Psychosomatic Medicine, 08.-11. Juni 2022, Wien.
[Vortrag, 11. Juni 2022]